Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA

 SummaryNewsCalendarCompanyFinancials 
Company
More about the company
Latest news on ARDEA BIOSCIENCES, INC.
2012 AstraZeneca hungry to refill medicine cabinet
2012DJAstraZeneca Completes Acquisition of Ardea Biosciences
2012 GSK goes hostile with $2.6 billion Human Genome offer
2012 Biotech targets fight back as Big Pharma circles
2012 ARDEA BIOSCIENCES, INC. : Securities Lawyers at Goldfarb LLP Seeking More Money,..
2012 Warner Chilcott to explore sale of company
2012 ARDEA BIOSCIENCES, INC. : Law Office of Brodsky & Smith, LLC Announces Investiga..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 AstraZeneca CEO quits as drug sales tumble
2012 Watson to buy Actavis for at least $5.6 billion
More news
Sector news : Bio Therapeutic Drugs
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
ARDEA BIOSCIENCES, INC..0
AMGEN, INC.12.79%121 448
CELGENE CORPORATION7.87%97 137
GILEAD SCIENCES, INC.-5.74%88 227
REGENERON PHARMACEUTIC..4.52%40 701
ACTELION LTD24.40%29 848
More Results